[(3S,5R)-3-amino-5-hydroxypiperidin-1-yl]-(4-methyl-2,3-dihydro-1,4-benzoxazin-7-yl)methanone;dihydrochloride
C15H23Cl2N3O3 — CID 154920500
Data last refreshed: (MolForge compound catalog, from PubChem)
About [(3S,5R)-3-amino-5-hydroxypiperidin-1-yl]-(4-methyl-2,3-dihydro-1,4-benzoxazin-7-yl)methanone;dihydrochloride
[(3S,5R)-3-amino-5-hydroxypiperidin-1-yl]-(4-methyl-2,3-dihydro-1,4-benzoxazin-7-yl)methanone;dihydrochloride (PubChem CID 154920500) has the molecular formula C15H23Cl2N3O3 and a molecular weight of 364.27 g/mol. Its IUPAC name is [(3S,5R)-3-amino-5-hydroxypiperidin-1-yl]-(4-methyl-2,3-dihydro-1,4-benzoxazin-7-yl)methanone;dihydrochloride.
Molecular Properties
| Compound Name | [(3S,5R)-3-amino-5-hydroxypiperidin-1-yl]-(4-methyl-2,3-dihydro-1,4-benzoxazin-7-yl)methanone;dihydrochloride |
|---|---|
| PubChem CID | 154920500 |
| Molecular Formula | C15H23Cl2N3O3 |
| Molecular Weight | 364.27 g/mol |
| Exact Mass | 363.11 |
| IUPAC Name | [(3S,5R)-3-amino-5-hydroxypiperidin-1-yl]-(4-methyl-2,3-dihydro-1,4-benzoxazin-7-yl)methanone;dihydrochloride |
| SMILES | CN1CCOc2cc(C(=O)N3C[C@@H](N)C[C@@H](O)C3)ccc21.Cl.Cl |
| InChI | InChI=1S/C15H21N3O3.2ClH/c1-17-4-5-21-14-6-10(2-3-13(14)17)15(20)18-8-11(16)7-12(19)9-18;;/h2-3,6,11-12,19H,4-5,7-9,16H2,1H3;2*1H/t11-,12+;;/m0../s1 |
| InChIKey | YEFHNYHRIFKNPB-UVDYRLMLSA-N |
| XLogP | 0.89 |
| TPSA | 79.03 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 1 |
| Heavy Atoms | 23 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 364.27 |
| LogP ≤ 5 | 0.89 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 154920500 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.